141 related articles for article (PubMed ID: 29969108)
21. Evaluation of Weighted Diffusion Subtraction for Detection of Clinically Significant Prostate Cancer.
Sato T; Isoda H; Fujimoto K; Furuta A; Fujimoto M; Ito K; Kobayashi T; Nakamoto Y
J Magn Reson Imaging; 2021 Dec; 54(6):1979-1988. PubMed ID: 34085328
[TBL] [Abstract][Full Text] [Related]
22. Prostate heterogeneity correlates with clinical features on multiparametric MRI.
Chen C; Yang Z; Sweeney E; Hectors SJ; Hu JC; Margolis DJ
Abdom Radiol (NY); 2021 Nov; 46(11):5369-5376. PubMed ID: 34292363
[TBL] [Abstract][Full Text] [Related]
23. Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.
Fedorov A; Vangel MG; Tempany CM; Fennessy FM
Invest Radiol; 2017 Sep; 52(9):538-546. PubMed ID: 28463931
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic evaluation of diffusion kurtosis imaging for prostate cancer: Detection in a biopsy population.
Ding K; Yao Y; Gao Y; Lu X; Chen H; Tang Q; Hua C; Zhou M; Zou X; Yin Q
Eur J Radiol; 2019 Sep; 118():138-146. PubMed ID: 31439233
[TBL] [Abstract][Full Text] [Related]
25. Unshielded asymmetric transmit-only and endorectal receive-only radiofrequency coil for (23) Na MRI of the prostate at 3 tesla.
Farag A; Peterson JC; Szekeres T; Bauman G; Chin J; Romagnoli C; Bartha R; Scholl TJ
J Magn Reson Imaging; 2015 Aug; 42(2):436-45. PubMed ID: 25407847
[TBL] [Abstract][Full Text] [Related]
26. Contribution of Histopathologic Tissue Composition to Quantitative MR Spectroscopy and Diffusion-weighted Imaging of the Prostate.
Kobus T; van der Laak JA; Maas MC; Hambrock T; Bruggink CC; Hulsbergen-van de Kaa CA; Scheenen TW; Heerschap A
Radiology; 2016 Mar; 278(3):801-11. PubMed ID: 26418614
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic performance of diffusion-weighted imaging for prostate cancer: Peripheral zone versus transition zone.
Lee H; Hwang SI; Lee HJ; Byun SS; Lee SE; Hong SK
PLoS One; 2018; 13(6):e0199636. PubMed ID: 29933396
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and Accuracy of MRI-Ultrasound Fusion Targeted Biopsy Based on PI-RADS v2.1 Category in Transition/Peripheral Zone of the Prostate.
Liu Y; Wang S; Xu G; Zhou B; Zhang Y; Ye B; Xiang L; Zhang Y; Xu H
J Magn Reson Imaging; 2023 Sep; 58(3):709-717. PubMed ID: 36773016
[TBL] [Abstract][Full Text] [Related]
29. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.
Sato C; Naganawa S; Nakamura T; Kumada H; Miura S; Takizawa O; Ishigaki T
J Magn Reson Imaging; 2005 Mar; 21(3):258-62. PubMed ID: 15723379
[TBL] [Abstract][Full Text] [Related]
30. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
31. Value of T
Klingebiel M; Schimmöller L; Weiland E; Franiel T; Jannusch K; Kirchner J; Hilbert T; Strecker R; Arsov C; Wittsack HJ; Albers P; Antoch G; Ullrich T
J Magn Reson Imaging; 2022 Aug; 56(2):413-422. PubMed ID: 35038203
[TBL] [Abstract][Full Text] [Related]
32. Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?
An JY; Harmon SA; Mehralivand S; Czarniecki M; Smith CP; Peretti JA; Wood BJ; Pinto PA; Choyke PL; Shih JH; Turkbey B
Abdom Radiol (NY); 2018 Dec; 43(12):3436-3444. PubMed ID: 29752491
[TBL] [Abstract][Full Text] [Related]
33. Optimizing size thresholds for detection of clinically significant prostate cancer on MRI: Peripheral zone cancers are smaller and more predictable than transition zone tumors.
Mahjoub S; Baur ADJ; Lenk J; Lee CH; Hartenstein A; Rudolph MM; Cash H; Hamm B; Asbach P; Haas M; Penzkofer T
Eur J Radiol; 2020 Aug; 129():109071. PubMed ID: 32531720
[TBL] [Abstract][Full Text] [Related]
34. Zone-specific logistic regression models improve classification of prostate cancer on multi-parametric MRI.
Dikaios N; Alkalbani J; Abd-Alazeez M; Sidhu HS; Kirkham A; Ahmed HU; Emberton M; Freeman A; Halligan S; Taylor S; Atkinson D; Punwani S
Eur Radiol; 2015 Sep; 25(9):2727-37. PubMed ID: 25680730
[TBL] [Abstract][Full Text] [Related]
35. Stiffness of benign and malignant prostate tissue measured by shear-wave elastography: a preliminary study.
Rouvière O; Melodelima C; Hoang Dinh A; Bratan F; Pagnoux G; Sanzalone T; Crouzet S; Colombel M; Mège-Lechevallier F; Souchon R
Eur Radiol; 2017 May; 27(5):1858-1866. PubMed ID: 27553936
[TBL] [Abstract][Full Text] [Related]
36. T2-weighted prostate MRI at 7 Tesla using a simplified external transmit-receive coil array: correlation with radical prostatectomy findings in two prostate cancer patients.
Rosenkrantz AB; Zhang B; Ben-Eliezer N; Le Nobin J; Melamed J; Deng FM; Taneja SS; Wiggins GC
J Magn Reson Imaging; 2015 Jan; 41(1):226-32. PubMed ID: 24259458
[TBL] [Abstract][Full Text] [Related]
37. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers.
Langer DL; van der Kwast TH; Evans AJ; Sun L; Yaffe MJ; Trachtenberg J; Haider MA
Radiology; 2008 Dec; 249(3):900-8. PubMed ID: 19011187
[TBL] [Abstract][Full Text] [Related]
38. Do apparent diffusion coefficient (ADC) values obtained using high b-values with a 3-T MRI correlate better than a transrectal ultrasound (TRUS)-guided biopsy with true Gleason scores obtained from radical prostatectomy specimens for patients with prostate cancer?
Kitajima K; Takahashi S; Ueno Y; Miyake H; Fujisawa M; Kawakami F; Sugimura K
Eur J Radiol; 2013 Aug; 82(8):1219-26. PubMed ID: 23518144
[TBL] [Abstract][Full Text] [Related]
39. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
[TBL] [Abstract][Full Text] [Related]
40. Prostate cancer aggressiveness: in vivo assessment of MR spectroscopy and diffusion-weighted imaging at 3 T.
Kobus T; Vos PC; Hambrock T; De Rooij M; Hulsbergen-Van de Kaa CA; Barentsz JO; Heerschap A; Scheenen TW
Radiology; 2012 Nov; 265(2):457-67. PubMed ID: 22843767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
